Cargando…

Elevation of Plasma Homocysteine and Minor Hallucinations in Parkinson's Disease: A Cross-Sectional Study

PURPOSE: Minor hallucinations (MHs) are the most common psychotic phenomena in Parkinson's disease (PD), and it has important clinical and prognostic implications in PD. Plasma homocysteine (Hcy) has been reported to predict the outcome of PD; whether or not Hcy is associated with MH is not kno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Min, Zhu, Sha, Gu, Ruxin, Wang, Yaxi, Jiang, Yinyin, Bai, Yu, Jiang, Xu, Shen, Bo, Yan, Jun, Pan, Yang, Zhu, Jun, Zhang, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920637/ https://www.ncbi.nlm.nih.gov/pubmed/35295686 http://dx.doi.org/10.1155/2022/4797861

Ejemplares similares

Clinical features of minor hallucinations in different phenotypes of Parkinson’s disease: A cross-sectional study
por: Wang, Yaxi, et al.
Publicado: (2023)

Aberrant gray matter volume and functional connectivity in Parkinson’s disease with minor hallucination
por: Zhong, Min, et al.
Publicado: (2022)

Characteristics of sleep structure in Parkinson's disease patients with hallucinations based on polysomnography
por: Gu, Ruxin, et al.
Publicado: (2022)

Prevalence and Risk Factors for Minor Hallucinations in Patients with Parkinson's Disease
por: Zhong, Min, et al.
Publicado: (2021)

Minor hallucinations in Parkinson’s disease with probable rapid eye movement sleep behavior disorder
por: Jiang, Yinyin, et al.
Publicado: (2023)

Clinical Features in Parkinson’s Disease Patients with Hyperechogenicity in Substantia Nigra: A Cross-Sectional Study
por: Zhu, Sha, et al.
Publicado: (2022)

Gait Analysis with Wearables Is a Potential Progression Marker in Parkinson’s Disease
por: Zhu, Sha, et al.
Publicado: (2022)

Correction: Zhu et al. Gait Analysis with Wearables Is a Potential Progression Marker in Parkinson’s Disease. Brain Sci. 2022, 12, 1213
por: Zhu, Sha, et al.
Publicado: (2023)

Sleep structure and related clinical characteristics in drug-naïve Parkinson's disease with subjectively different sleep quality
por: Jiang, Yinyin, et al.
Publicado: (2023)

Alterations of Regional Homogeneity in Parkinson’s Disease with Rapid Eye Movement Sleep Behavior Disorder
por: Jiang, Xu, et al.
Publicado: (2022)

Clinical Characteristics of Minor Hallucinations in Chinese Parkinson's Disease Patients
por: Zhang, Yu, et al.
Publicado: (2022)

The Association Between Clinical Characteristics and Motor Symptom Laterality in Patients With Parkinson's Disease
por: Zhu, Sha, et al.
Publicado: (2021)

Sleep Disturbances and Associated Factors in Drug-Naïve Patients with Parkinson’s Disease
por: Zhong, Min, et al.
Publicado: (2021)

Increased Cortical Thickness in Attentional Networks in Parkinson's Disease with Minor Hallucinations
por: Sawczak, Caspian M., et al.
Publicado: (2019)

Knowledge domain and emerging trends in visual hallucination research: A scientometric analysis
por: Zhong, Min, et al.
Publicado: (2021)

Subclinical Elevation of Plasma C-Reactive Protein and Illusions/Hallucinations in Subjects with Parkinson’s Disease: Case–control Study
por: Sawada, Hideyuki, et al.
Publicado: (2014)

Elevated Plasma Homocysteine Concentration in Opium-Addicted Individuals
por: Masoomi, Mohammad, et al.
Publicado: (2015)

Plasma homocysteine is elevated in COPD patients and is related to COPD severity
por: Seemungal, Terence AR, et al.
Publicado: (2007)

Elevated Plasma Homocysteine Levels in Anti-N-methyl-D-aspartate Receptor Encephalitis
por: Liu, Lizhi, et al.
Publicado: (2019)

Gait Analysis of Old Individuals with Mild Parkinsonian Signs and Those Individuals’ Gait Performance Benefits Little from Levodopa
por: Wu, Zhuang, et al.
Publicado: (2021)

Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐up
por: van Mierlo, Tom J. M., et al.
Publicado: (2021)

Visual hallucinations in the differential diagnosis of parkinsonism
por: Bertram, Kelly, et al.
Publicado: (2012)

Risk of Dementia Associated with Elevated Plasma Homocysteine in a Latin American Population
por: Chacón, Inara J., et al.
Publicado: (2009)

Elevated Plasma Homocysteine Level in Vascular Dementia Reflects the Vascular Disease Process
por: Nilsson, Karin, et al.
Publicado: (2013)

Elevated plasma homocysteine levels are associated with impaired peripheral microvascular vasomotor response
por: Toya, Takumi, et al.
Publicado: (2020)

Methylenetetrahydrofolate reductase polymorphisms and elevated plasma homocysteine levels in small vessel disease
por: Chen, Lei, et al.
Publicado: (2023)

The Combination of Homocysteine and C-Reactive Protein Predicts the Outcomes of Chinese Patients with Parkinson's Disease and Vascular Parkinsonism
por: Zhang, Limin, et al.
Publicado: (2011)

A Mendelian Randomization Study of Plasma Homocysteine and Multiple Myeloma
por: Xuan, Yang, et al.
Publicado: (2016)

Sleep-related hallucinations in patients with Parkinson’s disease
por: Komagamine, Tomoko, et al.
Publicado: (2022)

Elevated Homocysteine Levels Predict Hospital-Acquired Pneumonia and Poor Functional Outcomes in Primary Intracerebral Hemorrhage
por: Peng, Jun, et al.
Publicado: (2022)

Association between Elevated Plasma Homocysteine and Low Skeletal Muscle Mass in Asymptomatic Adults
por: Choi, Jae-Hyeong, et al.
Publicado: (2022)

A compound reflects the level of homocysteine based on Rhodamine B and its ability to respond to homocysteine in the plasma of diabetic patients
por: Zhao, Weiyu, et al.
Publicado: (2020)

Plasma homocysteine level is a risk factor for osteoporotic fractures in elderly patients
por: Zhu, Yuefeng, et al.
Publicado: (2016)

Multimodal MRI of the hippocampus in Parkinson’s disease with visual hallucinations
por: Yao, Nailin, et al.
Publicado: (2014)

Hallucinations and conscious access to visual inputs in Parkinson’s disease
por: Lefebvre, Stéphanie, et al.
Publicado: (2016)

Reduced occipital GABA in Parkinson disease with visual hallucinations
por: Firbank, Michael J., et al.
Publicado: (2018)

Genetic risk scores and hallucinations in patients with Parkinson disease
por: Kusters, Cynthia D.J., et al.
Publicado: (2020)

Hallucinations in Parkinson’s disease: new insights into mechanisms and treatments
por: Weil, Rimona S, et al.
Publicado: (2020)

Visual hallucinations and inferior longitudinal fasciculus in Parkinson's disease
por: Yuki, Natsuko, et al.
Publicado: (2020)

Frequency and Determinants of Olfactory Hallucinations in Parkinson’s Disease Patients
por: Solla, Paolo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fcdjatdmheddeokhdi4r4vav2j